Document Detail


Impact of an extensive in situ component on the presence of residual disease in screen detected breast cancer.
MedLine Citation:
PMID:  1744869     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study investigates the histopathological characteristics of a consecutive series of 100 screen detected breast cancers in relation to residual disease. Tumour type, size, grade, resection margins and extent of primary or associated in situ disease were all assessed by one pathologist. Thirty-seven women underwent further surgery (wider excision or mastectomy) and the resected specimen was examined for residual in situ or invasive cancer. In total, 36 cancers had an extensive in situ component, of which 69% were predominantly intraduct carcinoma of comedo type. Of the 37 women who underwent further resection, 21 (57%) women had residual cancer. Of those with initial disease at the resection margin, 16/25 (64%) had residual disease. Five of 12 (42%) with disease close to (within 2-3 mm) but not at the margin had residual disease. Of those with an extensive in situ component, 18/25 (72%) had residual disease, whereas only 2/12 (17%) women with none or some in situ disease had residual cancer. In screen detected breast cancer, residual cancer was present in 72% of women with an extensive in situ component at initial surgery. These women comprise a group in which conservation surgery may be inappropriate if completeness of excision is considered a prerequisite for breast conserving surgery.
Authors:
I D Campbell; J M Theaker; G T Royle; R Coddington; R Carpenter; A Herbert; I Moore; C Rubin; I Taylor; P B Guyer
Related Documents :
12224799 - Traumatic stress symptoms among women with recently diagnosed primary breast cancer.
21623159 - Micrornas and lung cancer: from markers to targets.
17250429 - Burden of breast cancer in iran: a study of the tehran population based cancer registry.
8924399 - Delay in diagnosis and treatment of breast cancer: implications for education.
11208879 - Arm edema in breast cancer patients.
19074869 - Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs46...
18712449 - Age-, race-, and ethnicity-related differences in the treatment of nonmetastatic rectal...
3701479 - Cumulative exposure to arsenic and its relationship to respiratory cancer among copper ...
16670159 - Proliferative activity of human thyroid cells in various age groups and its correlation...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the Royal Society of Medicine     Volume:  84     ISSN:  0141-0768     ISO Abbreviation:  J R Soc Med     Publication Date:  1991 Nov 
Date Detail:
Created Date:  1992-01-15     Completed Date:  1992-01-15     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7802879     Medline TA:  J R Soc Med     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  652-6     Citation Subset:  IM    
Affiliation:
University Surgical Unit, Southampton General Hospital.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Breast Neoplasms / pathology*,  prevention & control,  surgery
Carcinoma in Situ / pathology*
Female
Humans
Mass Screening
Mastectomy
Reoperation
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Low dose botulinum toxin in spasmodic torticollis.
Next Document:  Rape and sexually transmitted diseases: patterns of referral and incidence in a department of genito...